[Cerebrotendinous xanthomatosis]
Publication year
2001Author(s)
Source
Nederlands Tijdschrift voor Geneeskunde, 145, 35, (2001), pp. 1673-7ISSN
Publication type
Article / Letter to editor
Display more detailsDisplay less details
Organization
Neurology
Journal title
Nederlands Tijdschrift voor Geneeskunde
Volume
vol. 145
Issue
iss. 35
Page start
p. 1673
Page end
p. 7
Subject
Pediatric Oncology. Treatment of children with cancer.; Neuromuscular and neurometabolic disorders; Kinderoncologie. Behandeling van kinderen met kanker.; Neuromusculaire en neurometabole aandoeningenAbstract
A 24-year-old woman and a 13-year-old boy had suffered from diarrhoea, walking disorders, visual complaints and other complaints for many years. Once the suspicion of cerebrotendinous xanthomatosis (CTX) had been confirmed with biochemical and genetic tests and treatment with chenodeoxycholic acid had been started, the diarrhoea disappeared and the neurological symptoms lessened. CTX is a rare, autosomal recessive metabolic disease. The clinical hallmarks are: bilateral juvenile cataract, chronic diarrhoea, progressive neurological symptoms and signs, and tendon xanthomas. The phenotypic variability often hinders the clinical diagnosis. The biochemical diagnosis can be made by determining the serum cholestanol level and the excretion of urinary bile alcohols, followed by a mutation analysis. CTX is a treatable disease and therefore an early diagnosis is important.
This item appears in the following Collection(s)
- Non RU Publications [15544]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.